The HCPLive rheumatoid arthritis page is a comprehensive resource for clinical news and insights on arthritis. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for RA, and more.
February 12th 2025
The Phase 2b RENOIR trial met its primary endpoint and key secondary endpoints in patients with RA in new 12-week data.
DAS28-ESR Scores Higher in Female Patients With Rheumatoid Arthritis in Remission
Women with rheumatoid arthritis (RA) in remission exhibited higher values of Disease Activity Score-28 for Rheumatoid Arthritis with erythrocyte sedimentation rate (DAS28-ESR) compared with men.
Addressing Social Determinants to Achieve Equity in Care for Patients with Rheumatoid Arthritis
Disease activity and burden were higher in patients with rheumatoid arthritis with Medicaid or Medicare coverage, African American patients, and those residing in Southern regions.
FDA Approves Sarilumab as First, Only Biologic Treatment for Polymyalgia Rheumatica
The approval was based on positive results from the Phase 3 SAPHYR trial, which showed that nearly 3 times more patients achieved sustained remission with sarilumab when compared with placebo.
Multidisciplinary Lifestyle Program Decreased Disease Activity in Patients With Rheumatoid Arthritis
“Reversing and preventing adverse lifestyle factors could potentially reduce the incidence and burden of rheumatoid arthritis, as well as alleviate its comorbidities,” investigators hypothesized.
Rheumatology Month in Review: January 2023
The January 2023 rheumatology month in review highlights a recent study that indicated an increased risk of hospitalization and death among patients with gout and COVID-19, the expansion of research evaluating adalimumab biosimilars, and trends in fibromyalgia.
Despite Research, Utility of Calprotectin as Biomarker in Rheumatoid Arthritis Still Unclear
January 26th 2023A meta-analysis with data from more than 30 published articles provides an overview of associations between calprotectin levels and disease activity, treatment response, and inflammation among patients with rheumatoid arthritis.
Patients With Inflammatory Arthritis Feel Positive Toward Most Vaccinations
General practitioners and rheumatologists were viewed as sources of information that led to positive views toward vaccinations, while internet chatrooms, social media, and mainstream media were seen as sources of information that led to negative views.
Targeting the MK2 Pathway Reduces Tachyphylaxis Related to Rheumatoid Arthritis Therapy
January 24th 2023P38 mitogen-activated protein kinase (p38 MAPK) inhibitors have been a focal point for inflammatory diseases but the lack of efficacy in treating rheumatoid arthritis led to examination of the MK2 pathway.